L-ascorbic acid/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases intensive care unit length of stay
StrongEvidence strength: strong. Randomised human trials or their synthesis, with the effect's size and interval recorded and no recorded weakness outstanding.Finding“Polling data from 30 studies reporting the length of ICU stay outcome using a random effect model showed an overall mean difference of −0.76 days, indicating a 0.76-day shorter ICU stay among the vitamin C group compared with placebo/SOC (95% CI, 95% CI, −1.34 to −0.19; n = 252,897; I2 = 96%; p = 0.009).”
Quoted verbatim from Vitamin C in Critically Ill Patients: An Updated Systematic Review and Meta-Analysis.. - Study
- meta-analysis
- Participants
- 252,897
- Population
- Critically ill adults; pooled randomized and observational studies of intravenous vitamin C alone or with other antioxidants versus placebo or standard of care
Effect -0.76 mean difference, 95% CI -1.34 to -0.19
Vitamin C in Critically Ill Patients: An Updated Systematic Review and Meta-Analysis.2021PMID:34684565Permalink
Keep reading
- Everything the graph holds on L-ascorbic acid
- Every compound studied against Intensive care unit length of stay
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PATM4176KG2PQ8TG283SZG